Cargando…
Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJE...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579953/ https://www.ncbi.nlm.nih.gov/pubmed/23440347 http://dx.doi.org/10.3402/ijch.v72i0.19743 |
_version_ | 1782260195405070336 |
---|---|
author | Severini, Alberto Jiang, Ying Brassard, Paul Morrison, Howard Demers, Alain A. Oguntuase, Elizabeth Al-Rushdi, Muna Preston, Felicia Ratnam, Samuel Mao, Yang |
author_facet | Severini, Alberto Jiang, Ying Brassard, Paul Morrison, Howard Demers, Alain A. Oguntuase, Elizabeth Al-Rushdi, Muna Preston, Felicia Ratnam, Samuel Mao, Yang |
author_sort | Severini, Alberto |
collection | PubMed |
description | BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJECTIVE: The objective of this study was to measure the HPV type prevalence in Labrador women to determine if significant differences in HPV types could reduce the effectiveness of HPV vaccination. DESIGN: The prevalence of HPV types was determined in 1,370 women presenting for routine pap screening in Labrador between February and November 2010. Cervical cytology and HPV genotyping were performed on the same liquid-based cytology specimens. RESULTS: The overall prevalence of HPV was 21.4%; cytological abnormalities were found in 8.8% of the participants. HPV 16 and 18 were the most common high-risk HPV types. These two types were found in 52.4% of high-grade lesions. The prevalence in HPV infections was comparable across the Labrador regions. CONCLUSIONS: The present results support the potential effectiveness of the HPV immunization program in Labrador. |
format | Online Article Text |
id | pubmed-3579953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Co-Action Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-35799532013-02-25 Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada Severini, Alberto Jiang, Ying Brassard, Paul Morrison, Howard Demers, Alain A. Oguntuase, Elizabeth Al-Rushdi, Muna Preston, Felicia Ratnam, Samuel Mao, Yang Int J Circumpolar Health Original Research Article BACKGROUND: A higher incidence of cervical cancer and human papillomavirus (HPV) infection has been reported in northern Canada and in First Nation, Métis and Inuit women, with some evidence to suggest that the HPV type distribution in these populations may be different from the rest of Canada. OBJECTIVE: The objective of this study was to measure the HPV type prevalence in Labrador women to determine if significant differences in HPV types could reduce the effectiveness of HPV vaccination. DESIGN: The prevalence of HPV types was determined in 1,370 women presenting for routine pap screening in Labrador between February and November 2010. Cervical cytology and HPV genotyping were performed on the same liquid-based cytology specimens. RESULTS: The overall prevalence of HPV was 21.4%; cytological abnormalities were found in 8.8% of the participants. HPV 16 and 18 were the most common high-risk HPV types. These two types were found in 52.4% of high-grade lesions. The prevalence in HPV infections was comparable across the Labrador regions. CONCLUSIONS: The present results support the potential effectiveness of the HPV immunization program in Labrador. Co-Action Publishing 2013-02-21 /pmc/articles/PMC3579953/ /pubmed/23440347 http://dx.doi.org/10.3402/ijch.v72i0.19743 Text en © 2013 Alberto Severini et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Severini, Alberto Jiang, Ying Brassard, Paul Morrison, Howard Demers, Alain A. Oguntuase, Elizabeth Al-Rushdi, Muna Preston, Felicia Ratnam, Samuel Mao, Yang Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada |
title | Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada |
title_full | Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada |
title_fullStr | Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada |
title_full_unstemmed | Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada |
title_short | Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada |
title_sort | type-specific prevalence of human papillomavirus in women screened for cervical cancer in labrador, canada |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579953/ https://www.ncbi.nlm.nih.gov/pubmed/23440347 http://dx.doi.org/10.3402/ijch.v72i0.19743 |
work_keys_str_mv | AT severinialberto typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT jiangying typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT brassardpaul typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT morrisonhoward typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT demersalaina typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT oguntuaseelizabeth typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT alrushdimuna typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT prestonfelicia typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT ratnamsamuel typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada AT maoyang typespecificprevalenceofhumanpapillomavirusinwomenscreenedforcervicalcancerinlabradorcanada |